Dems unveil bill for Medicare to negotiate drug prices

Dems unveil bill for Medicare to negotiate drug prices
© Greg Nash

Democrats on Thursday unveiled a bill to allow Medicare to negotiate drug prices, a key part of their agenda to lower pharmaceutical costs.

Sen. Sherrod BrownSherrod Campbell BrownBank watchdogs approve rule to loosen ban on risky Wall Street trades Dayton mayor assigned extra security following verbal spat with Trump The Hill's Campaign Report: Battle for Senate begins to take shape MORE (D-Ohio), who is considering a presidential run, and Rep. Lloyd DoggettLloyd Alton DoggettHere are the 95 Democrats who voted to support impeachment Speaker Pelosi, seize the moment to make history on drug pricing House Democrats sue Treasury to turn over Trump tax returns MORE (D-Texas), the chairman of the House Ways and Means Health Subcommittee, led the announcement at a press conference on Thursday.

ADVERTISEMENT
“What we're really doing today is just calling on President TrumpDonald John Trump Former US ambassador: 'Denmark is not a big fan of Donald Trump and his politics' Senate Democrats push for arms control language in defense policy bill Detroit county sheriff endorses Booker for president MORE to listen to candidate Trump,” Doggett said, pointing out that Trump supported Medicare negotiating drug prices in 2016 before backing off the idea.

While the odds are long the measure can get through the GOP-controlled Senate, Brown said he hoped a strong vote in the House would “put the pressure on [Senate Majority Leader] Mitch McConnellAddison (Mitch) Mitchell McConnellGOP group calls on Republican senators to stand up to McConnell on election security in new ads The Hill's Morning Report - Trump hews to NRA on guns and eyes lower taxes Hobbled NRA shows strength with Trump MORE.”

Other lawmakers said they hoped that if Trump came out in support of the bill, it would also pressure Senate Republicans.

Trump has put forward other ideas on drug pricing, some of which have received some Democratic support but that Democrats generally say do not go far enough.

Doggett said that, even in the House, the path forward for the bill remains unclear, given that committees are just beginning to hold hearings on the drug-pricing issue and there are multiple different bills on the topic.

Lowering drug prices was a key issue in last year’s campaign, and several newly elected Democrats, including Reps. Katie Porter (Calif.) and Andy Kim (N.J.), touted the bill at the press conference Thursday.

Rep. Peter WelchPeter Francis WelchOvernight Health Care: Oversight chair plans to call drug executives to testify on costs | Biden airs anti-'Medicare for All' video | House panel claims Juul deliberately targeted kids Mueller agrees investigation did not 'fail to turn up evidence of conspiracy' Live coverage: Mueller testifies before Congress MORE (D-Vt.) recalled his meeting with Trump in 2017 to discuss drug prices, saying the president expressed support for drug price negotiation in that meeting but never followed up.

“He said all the right things,” Welch said. “I thought I was meeting with [Sen.] Bernie SandersBernie SandersSenate Democrats push for arms control language in defense policy bill Top adviser on Sanders: 'He's always been underestimated' 'The Simpsons' pokes fun at Trump's feud with 'the squad' MORE.”